Aripiprazole therapy in 20 older adults with bipolar disorder: A 12-week, open-label trial

Journal of Clinical Psychiatry

Volumn 69, Issue 1, 2008, Pages 41-46

  Sajatovic, Martha ^a,e   Coconcea, Nicoleta ^b   Ignacio, Rosalinda V ^c,d   Blow, Frederic C ^c,d   Hays, Robert W ^b   Cassidy, Kristin A ^a   Meyer, William J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NorthEast Ohio Health Services   (United States)

^c Health Services Research and Development   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE;

ADULT; AGED; ARTICLE; BIPOLAR I DISORDER; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DRUG EFFECT; FEMALE; HAMILTON SCALE; HUMAN; HYPERSALIVATION; INSOMNIA; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RESTLESSNESS; SEDATION; SIDE EFFECT; TREATMENT DURATION; WEIGHT GAIN;

EID: 39549095096     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0106     Document Type: Article

References (43)

1. Centers for Disease Control and Prevention (CDC). Trends in aging - United States and worldwide. MMWR Morb Mortal Wkly Rep 2003;52:101-104, 106
2. Jeste DV, Alexopoulos S, Bartels S, et al. Consensus statement on the upcoming crisis in geriatric mental health. Arch Gen Psychiatry 1999;56:848-853
3. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003;64:53-59
4. Chen P, Ahmed M, Sajatovic M. Bipolar disorder in later life. J Aging Health. In press
5. Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord 2004;6:343-367
6. Young RC, Gyulai L, Mulsant BH, et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry 2004;12:342-357
7. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision). Am J Psychiatry 2002;159(suppl 4):1-50
8. Keck PE, Perlis RH, Otto MW, et al. The Expert Consensus Guideline Series: Treatment of Bipolar Disorder 2004. Postgrad Med Special Report Dec 2004:1-120
9. Gildengers AG, Mulsant BH, Begley AE, et al. A pilot study of standardized treatment in geriatric bipolar disorder. Am J Geriatr Psychiatry 2005;13:319-323
10. Young RC. Randomized, controlled trial of lithium vs valproate in geriatric mania. Presented at the 6th International Congress on Bipolar Disorder; June 16-18, 2005; Pittsburgh, Pa
11. Geddes J, Goodwin G, Rendell J, et al. New trial should clarify lithium use in bipolar disorder. BMJ 2002;325:441
12. Jordan S, Koprivica V, Chen R, et al. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol 2002;441:137-140
13. Lieberman JA. Dopamine partial agonists: a new class of antipsychotic. CNS Drugs 2004;18:251-267
14. Centorrino F, Fogarty KV, Cimbolli P, et al. Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients. J Psychiatr Pract 2005;11:241-247
15. Sheehan DV, Lecubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): development and validation of a Structured Diagnosis Psychiatric Interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33
16. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;23:56-62
18. Guy W. ECDEU Assessment Manual for Psychopharmacology, rev ed. US Department Health, Education, and Welfare Publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976
19. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-676
20. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;212:11-19
21. Beyer JL, Siegal A, Kennedy JS, et al. Olanzapine, divalproex and placebo treatment, non-head to head comparisons of older adult acute mania. Presented at the 53rd Institute on Psychiatric Services; October 10-14, 2001; Orlando, Fla
22. Madhusoodanan S, Brenner R, Araujo L, et al. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry 1995;56:514-518
23. Madhusoodanan S, Suresh P, Brenner R, et al. Experience with the atypical antipsychotics - risperidone and olanzapine in the elderly. Ann Clin Psychiatry 1999;11:113-118
24. Sajatovic M, Calabrese J, Mullen. Quetiapine for the treatment of bipolar mania in older adults. Presented at the 6th International Congress on Bipolar Disorder; June 16-18, 2005; Pittsburgh, Pa
25. Schulman RW, Singh A, Shulman KI. Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacol Bull 1997;33:113-118
26. Grunze H. Reevaluating therapies for bipolar depression. J Clin Psychiatry 2005;66(suppl 5):17-25
27. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:530-537
28. Nierenberg AA, Ostacher MJ, Calabrese JR, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inostitol, or risperidone. Am J Psychiatry 2006;163:210-216
29. Altshuler LL, Gitlin MJ, Mintz J, et al. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 2002;63:807-811
30. Depp CA, Davis CE, Mittal D, et el. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry 2006;67:215-221
31. Fuller M, Sajatovic M. Drug Information Handbook for Psychiatry, 3rd ed. Cleveland, Ohio: Lexi-Comp Inc; 2002
32. Yatham LN, Kennedy SH, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 2005;7(suppl 3):5-69
33. Simon JS, Nemeroff CB. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder. J Clin Psychiatry 2005;66:1216-1220
34. Ostroff RB, Nelson JC. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. J Clin Psychiatry 1999;60:256-259
35. Papakostas GI, Petersen TJ, Nierenberg AA, et al. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. J Clin Psychiatry 2004;65:217-221
36. Shelton RC, Tollefson GD, Tohen M, et al. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 2001;158:131-134
37. Rausch JL, Ruegg R, Moeller FG. Gepirone as a 5-HT 1A agonist in the treatment of major depression. Psychopharmacol Bull 1990;26:169-173
38. Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351-1360
39. Tohen MF, Ketter TA, Calabrese JR, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-1088
40. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs atypical antipsychotic medications. N Engl J Med 2005;353:2335-2341
41. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-1943
42. U.S. Food and Drug Administration Center for Drug Evaluation and Research Public Health Advisory, Deaths with antipsychotics in elderly patients with behavioral disturbances. April 11, 2005
43. Enger C, Weatherby L, Reynolds RF, et al. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis 2004;192:19-27